Vorinostat and Isotretinoin in Treating Patients With Advanced Kidney Cancer

Clinical trial NCT00324740 · TERMINATED

Trial details

NCT number: NCT00324740
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer

Start date: 2006-03-01
Primary completion: 2011-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.